Kiwoom Securities Co., Ltd. (KRX:039490) earned ₩680.6bn in the June quarter. Net profit was up 119% on a year earlier, operating profit up 93% to ₩788.9bn, and the trailing four quarters have now produced ₩1,727bn.
The stock closed at ₩274,000 on September 2, down 45% from its 52-week high of ₩495,500.
Which puts the shares at about 4.2 times trailing earnings and 0.95 times book. A company that just earned a 23% return on equity is being priced below the value of that equity.
There's a lazy read here — Korea discount, value trap, nobody understands Korean brokers. And a more useful one: the market has looked at where those earnings come from and priced them as a peak. On the evidence, that view is defensible. The interesting question is which parts of the record are cyclical and which parts aren't, because the multiple treats all of it as the former.
Split the June quarter. Brokerage commission revenue on stock trading was ₩451.9bn against ₩162.4bn a year earlier — up 178%. Net interest income, meaning interest income of ₩592.3bn less interest expense of ₩399.0bn, was ₩193.3bn against ₩187.4bn in the same quarter of 2025. Up about 3%.
So the ₩380bn increase in quarterly operating profit is essentially one line, and that line is a direct function of how much Koreans traded. Reported average daily trading value ran near ₩36.3tn in the quarter against ₩10.8tn a year earlier — more than triple.
Commission revenue on a per-trade basis is thin and getting thinner; Kiwoom built its position by charging less than the branch brokers. What it has instead is volume, and volume in Korean equities is one of the more volatile series in global finance. Retail turnover in Korea can fall by two-thirds in a year without a recession, and has.
That's why 4.2 times earnings isn't the market being stupid. It's the market saying ₩680bn a quarter is not the base.
Look at what happened to the balance sheet while this was going on. Total assets were ₩55.7tn at the end of 2024, ₩81.2tn at the end of 2025, and ₩108.3tn in June. Equity over the same stretch went from ₩5.63tn to ₩7.58tn.
Assets roughly doubled; equity rose about a third. Leverage went from just under 10 times to 14.3 times.
For a broker this is less alarming than it looks, and worth explaining because the cash flow statement will scare anyone reading it as a manufacturer's. Kiwoom reported negative ₩8,610.8bn of operating cash flow in the June quarter and positive ₩9,050.4bn from financing. That is not a company burning money. It's a broker whose operating assets — margin loans to customers, securities held for trading, receivables from settlement — count as operating outflows when they grow, funded by borrowing that counts as financing inflows. Full-year 2025 looked the same: negative ₩6,400bn operating, positive ₩8,498bn financing.
But the leverage is real leverage. Fourteen times equity against a book where a large chunk is lending to retail investors buying stocks with borrowed money, in a market that has just tripled its turnover. If trading value falls, the commissions go first and the credit quality of the margin book goes second.
Korea gives you an unusually good early-warning instrument for that, and it has no direct US equivalent. Margin loan balances — money lent by brokers to retail investors to buy shares — are published for the whole market on a daily basis by the Korea Financial Investment Association. FINRA publishes US margin debt monthly, with a lag. In Korea the number lands every day. Anyone who wants to see Kiwoom's cycle turn before the quarterly results arrive can watch that series.
One line in this business is doing something structurally different, and it doesn't get enough attention outside Korea.
Korean retail investors have become large, persistent buyers of US-listed equities. Brokerages collected roughly $700 million in overseas trading fees in the second quarter, according to Korean reporting on the sector. Those fees carry higher rates than domestic commissions, and the underlying behaviour — a Korean household holding Nvidia or an S&P 500 ETF as a core position — looks more like an allocation decision than a trading decision.
That matters for the multiple. Domestic turnover is a sentiment variable. Cross-border allocation is a savings variable, and savings variables mean-revert far more slowly. If a meaningful share of the current run rate is overseas trading rather than KOSPI day-trading, then the earnings base after this cycle is higher than the last one.
Kiwoom's disclosure doesn't break that out cleanly enough for me to size it here. It's the number I'd most want and don't have.
Market capitalization is ₩7.19tn against equity of ₩7.58tn — roughly $5.2bn at about 1,370 won to the dollar, an approximate rate. The 52-week range is ₩201,000 to ₩495,500, so the stock is 36% above its low while earning three times what it did at that low.
Work backwards from the price. If the shares are worth book value, the market is assuming Kiwoom's sustainable return on equity is roughly its cost of equity — call it 10-12%. Trailing return on equity is 22.8%. So the price implies the earnings power halves from here and stays halved.
Is that fair? In 2023 Kiwoom earned ₩440.7bn for the full year. In 2021, ₩910.2bn. In 2024, ₩834.9bn. The 2023 trough was less than a quarter of what the company earned in the last twelve months. On that history, a halving is not a pessimistic assumption. It's roughly the average of the last five years applied forward.
The 2025 cash flow statement shows ₩205.7bn of dividends paid, up from ₩88.1bn in 2024. Against the current market capitalization that is a shade under 3%, though the payout tracks the earnings cycle and 2024's figure shows how fast it can shrink.
The obvious one is that this is a single-variable stock and the variable is sentiment. Korean turnover fell hard in 2022 and 2023 and there was no macro event you could point at. It can do it again.
The margin book is the amplifier. Lending against securities is a fine business until prices fall, at which point forced selling drives the prices that trigger more forced selling. Fourteen times leverage means the equity has less room than it did in the last downturn, when the company entered at ten times.
Regulatory risk in Korean brokerage has a specific shape: rules around short selling, margin lending limits, and retail protection change with political weather, and they change fast. A rule that caps margin loan growth would hit the interest line and the commission line at once.
And competition. Kiwoom's moat is price, which is the moat most easily attacked. Toss Securities and the bank-affiliated platforms are pushing at the same retail base with the same argument Kiwoom once used against the branch brokers.
Daily trading value, first and always. If it stabilizes near ₩30tn a day, the current earnings are closer to a base than a peak and 4.2 times is wrong. If it reverts toward ₩15tn, the market's implied forecast is right and the stock is fairly priced on earnings it hasn't reported yet.
Second, the third-quarter breakdown of commission revenue between domestic and overseas. That single split is the difference between a cyclical broker and a broker with a growing annuity attached.
Third, the margin loan balance series through the autumn. It leads the commission line, it's published daily, and it costs nothing to watch.
kstock reads DART every morning and writes up what moved — the contract, the buyback, the number that does not add up. The daily post and a Saturday roundup, by email.